CNF Investments

CNF Investments, LLC (CNF) is a private investment firm with a focus on venture capital and private equity opportunities. CNF manages over $350 million in capital, with current investments in technology, healthcare, and energy, and will consider direct as well as fund investments. CNF is an active investor that looks to partner with experienced and passionate entrepreneurs and co-investors to build great companies. CNF focuses on growth stage companies, but will consider investments in early and late stage businesses as well. CNF conducts thorough and efficient diligence processes but focuses most of its analysis on the potential investment's management team and other key players. CNF believes that success is based on the right combination of people, experience, hard work, focus, and execution. CNF is an affiliate of Clark Enterprises, Inc.

46 past transactions

Ceros

Series C in 2019
Ceros is a cloud-based experiential content creation platform that empowers marketers and designers to create rich, interactive content without code or traditional web development.

Svelte Medical Systems

Venture Round in 2018
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Ceros

Series B in 2016
Ceros is a cloud-based experiential content creation platform that empowers marketers and designers to create rich, interactive content without code or traditional web development.

Svelte Medical Systems

Private Equity Round in 2016
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Blitsy

Series B in 2016
Blitsy is where creative people shop online. It aims to provide the best selection, value, inspiration, and online shopping experience for creative people worldwide. It was founded in 2011 and is based in Chicago, Illinois.

Upskill

Venture Round in 2015
Upskill provides wearable technology to connect hands-on workers from the factory to the warehouse to the jobsite. Its robust platform, Skylight, connects the industrial workforce with the people, processes, information, and equipment they need to do their jobs with greater efficiency and fewer errors, leaving them hands free to focus on their tasks at hand, and their tools. For organizations in the competitive global market looking to increase productivity, improve quality, reduce costs, train new workers, retain tribal knowledge, and provide a strong foundation for further investments, the future starts with Upskill.

Kareo

Series G in 2015
Kareo is the leading cloud-based, clinical and business management platform designed specifically for the independent practice. Kareo’s integrated modules work together as part of a seamless platform, so independent practices have helpful tools to tackle their toughest administrative challenges. These tools include electronic health records, practice management, billing, marketing and patient engagement software. Plus, proven, integrated third-party applications and services in Kareo Marketplace to make delivering care even easier. Today we help over 50,000 providers in all 50 states run more efficient and profitable practices, while delivering outstanding patient care. Kareo has received extensive industry recognition, including being awarded the 2018 United States Ambulatory EHR Enabling Technology Leadership Award from Frost and Sullivan, Deloitte Technology Fast 500, Inc. 5000 and Black Book’s #1 Integrated EHR, Practice Management and Medical Billing Vendor. With offices across the country, our mission is to help independent practices succeed in an ever-changing healthcare market.

CircleBack

Series C in 2015
Founded outside of Washington DC, CircleBack, Inc. is a technology company dedicated to solving a major productivity problem: keeping contact data accurate. Using a patented data engine, CircleBack lets you know when connections change jobs, companies, email addresses, and work numbers, delivering these updates directly to mobile address books and CRMs. This makes it easier than ever for both professionals and businesses to keep connections alive and get stuff done faster and with more accuracy.

Ingo Money

Venture Round in 2015
Ingo Money, Inc. provides an Ingo Money application to cash paychecks, personal checks, business checks, money orders, and more on mobile devices. It offers Ingo Push, a Software-as-a-Service platform for instant loan proceeds to small business customers; Ingo Check, an instant money service for digital disbursements through a mobile device; Ingo Cash, a solution that turn cash into real-time digital deposits and payments; and Ingo Money QuickConnect, a solution that allows any company issuing disbursements to customers to begin offering push-to-card payments through visa direct. Ingo Money, Inc. was formerly known as CHEXAR Networks, Inc. and changed its name to Ingo Money, Inc. in June 2013. The company was founded in 2001 and is based in Alpharetta, Georgia.

Vascular Therapies

Private Equity Round in 2015
Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.

Orchestro

Venture Round in 2014
Orchestro develops a software-as-a-service-based demand signal management platform. They enable consumer products companies to consolidate point-of-sale, internal, and syndicated data to create dashboards for category analysts, national account managers, and international representatives.

Echo360

Series C in 2014
Echo360 combines all of the video capabilities into a single, smart solution that is so easy to manage. It aims to transform teaching and learning through active learning technology. Echo360 was formed as a subsidiary of Anystream, the world leader in digital media production and workflow management solutions for major media companies. Drawing on a proven track record and history as a technology innovator combined with a clear vision of how technology could better serve education institutions and students around the world, Echo360 has emerged as the global leader in active learning technology. It was founded in 2007 and is headquartered in Dulles, Virginia.

AnyPresence

Series B in 2014
AnyPresence is an enterprise platform for the app economy that dramatically reduces the time and cost of mobile-enabling enterprise business processes, products, and services. It is the only solution that offers organizations the ability to assemble and deploy backend servers, native iOS, native Android, and HTML5 mobile apps with 100% native, portable source code. The patent-pending AnyPresence platform also includes the ability to generate sample mobile apps from within API management portals, increasing adoption, and accelerating time-to-market for apps that incorporate a company's data or services. The platform is easy to use, yet flexible enough to enable source code-level customization or on-premise hosting options.

SurfWatch Labs

Series A in 2014
SurfWatch Labs helps organizations and service providers quickly establish a strategic cyber threat intelligence operation that drives more effective use of their tactical defenses. Founded in 2013 by former US Government intelligence analysts, SurfWatch Labs solutions provide a 360-degree view of cyber threats in the context of your business, along with practical and personalized support to create immediate insights and meaningful action. Combining useful analytics, applications, and human expertise, SurfWatch solutions can be an off-the-shelf, cyber threat intelligence team or delivered as a comprehensive product suite that easily integrates with the existing cybersecurity operations.

Closely

Series A in 2014
Closely centers itself squarely behind the local merchant, equipping small business owners to succeed with everyday social & mobile marketing and to connect with the fast-changing online, social & mobile behavior of their customers. By providing simple tools for local merchants to promote their business, create loyal customers, & make better use of their resources, Closely empowers small businesses to participate more effectively in their local marketplace.

Quad Learning

Series B in 2014
Quad Learning, Inc. was founded in 2012 with the goal of creating more affordable pathways for students to earn their bachelor’s degree. Quad Learning is a venture-backed startup that collaborates with leading community colleges to jointly develop and deliver American Honors, a competitive 2-year honors program designed for high ability students who plan to complete the remainder of their bachelor’s degree at a top-tier college or university.

Svelte Medical Systems

Venture Round in 2014
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Speek

Series A in 2014
At Speek they’re dedicated to bringing you super simple conference calling with no dial-ins, pins or downloads. Speek uses a personal or business link (i.e., speek.com/YourName) instead of a phone number and PIN for conference calls. Participants click the Speek link to start or join a call from their phone, web or mobile browser. You can see who’s joined, who’s talking, share files, use call controls and more. Speek has recently raised $1.1 million in bridge funding in advance of its series A. The round was oversubscribed and led by existing investors. Speek has raised a total of $2.6 million to date.

Kareo

Series F in 2014
Kareo is the leading cloud-based, clinical and business management platform designed specifically for the independent practice. Kareo’s integrated modules work together as part of a seamless platform, so independent practices have helpful tools to tackle their toughest administrative challenges. These tools include electronic health records, practice management, billing, marketing and patient engagement software. Plus, proven, integrated third-party applications and services in Kareo Marketplace to make delivering care even easier. Today we help over 50,000 providers in all 50 states run more efficient and profitable practices, while delivering outstanding patient care. Kareo has received extensive industry recognition, including being awarded the 2018 United States Ambulatory EHR Enabling Technology Leadership Award from Frost and Sullivan, Deloitte Technology Fast 500, Inc. 5000 and Black Book’s #1 Integrated EHR, Practice Management and Medical Billing Vendor. With offices across the country, our mission is to help independent practices succeed in an ever-changing healthcare market.

Viridis Learning

Seed Round in 2013
Viridis, a human capital technology SaaS solution, that matches skill deficiencies with local employer needs of middle skill labor.

Speek

Seed Round in 2013
At Speek they’re dedicated to bringing you super simple conference calling with no dial-ins, pins or downloads. Speek uses a personal or business link (i.e., speek.com/YourName) instead of a phone number and PIN for conference calls. Participants click the Speek link to start or join a call from their phone, web or mobile browser. You can see who’s joined, who’s talking, share files, use call controls and more. Speek has recently raised $1.1 million in bridge funding in advance of its series A. The round was oversubscribed and led by existing investors. Speek has raised a total of $2.6 million to date.

ReelGenie

Seed Round in 2013
ReelGenie is bringing the power of video storytelling to businesses. Their innovative technology enables customers to transform their photos and stories into videos that can be shared with the world. By empowering people to tell their stories through video, ReelGenie's easy-to-integrate solutions pave the way to better brand engagement and brand new revenues.

TerraGo Technologies

Series C in 2013
TerraGo Technologies delivers software applications that extend the access and application of maps and images for non-GIS users and customers. More than 850 organizations, including many defense and intelligence agencies, utility and energy companies, public safety departments, and environmental engineering teams depend on TerraGo software. The TerraGo Publisher Suite allows organizations to consume and optimize data from any source and create a geo-enabled PDF, also known as a GeoPDF. The TerraGo Collaboration Suite offers desktop, web-based, and mobile software applications that automate geospatial collaboration and information gathering.

ViewLift

Venture Round in 2013
The future of video distribution & revenue is digital, through mobile, OTT, IPTV, Smart TVs & more. ViewLift is a full-service video platform for publishers to distribute and monetize their content through custom branded native applications on every major digital device. Thanks to ViewLift, it has never been easier for companies to engage directly with consumers, streaming their video content across devices and reaching target audiences in today's rapidly evolving media landscape.

SnagFilms

Venture Round in 2013
SnagFilms Inc. is an online film distribution company that provides audiences with the opportunity to watch, share, and support a wide array of films and documentaries. Established in 2007 and headquartered in New York, the platform offers thousands of full-length movies, TV shows, and documentaries across various genres, including comedy, drama, science, and horror. Viewers can access content on multiple devices, including mobile phones, tablets, desktops, and TVs, and the service features multi-lingual options to cater to a diverse audience. SnagFilms aims to make independent and award-winning films accessible to a broader community while fostering a culture of support for filmmakers.

Speek

Seed Round in 2013
At Speek they’re dedicated to bringing you super simple conference calling with no dial-ins, pins or downloads. Speek uses a personal or business link (i.e., speek.com/YourName) instead of a phone number and PIN for conference calls. Participants click the Speek link to start or join a call from their phone, web or mobile browser. You can see who’s joined, who’s talking, share files, use call controls and more. Speek has recently raised $1.1 million in bridge funding in advance of its series A. The round was oversubscribed and led by existing investors. Speek has raised a total of $2.6 million to date.

Revance Therapeutics

Series D in 2011
Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems.

Flyby Media

Series A in 2010
Flyby Media is a venture-backed company that develops next-generation consumer mobile social applications that connect the physical world with digital content. Its team of mobile industry entrepreneurs and computer vision scientists is dedicated to building new technology that can elevate, rather than replace, real-world experiences. Founded in 2010, Flyby Media is headquartered in New York.

Svelte Medical Systems

Debt Financing in 2009
Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products. Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES). Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

TerraGo Technologies

Venture Round in 2009
TerraGo Technologies delivers software applications that extend the access and application of maps and images for non-GIS users and customers. More than 850 organizations, including many defense and intelligence agencies, utility and energy companies, public safety departments, and environmental engineering teams depend on TerraGo software. The TerraGo Publisher Suite allows organizations to consume and optimize data from any source and create a geo-enabled PDF, also known as a GeoPDF. The TerraGo Collaboration Suite offers desktop, web-based, and mobile software applications that automate geospatial collaboration and information gathering.

Overture Technologies

Series C in 2008
Overture Technologies, Inc. develops and markets software solutions and consulting services to the residential lending and student financial aid industries. The company offers education finance solutions, including Conductor, an online financial aid solution, which provides personalized guidance, counseling, and services for students and their parents about their funding options; Student Loan Marketplace that enables users to compare loan terms from multiple lenders; and Amadeus, an underwriting and pricing solution for the student loan industry. It also provides Mortgage Finance Solutions, which promotes market efficiency and risk management for underwriting, pricing, servicing, and valuing mortgage loans and assets. The company's Mortgage Finance Solutions comprise Mozart for Special Servicing, which provides a set of alternatives for borrowers that can reduce repeat default rates and preserve the value of mortgage assets; Mozart for Acquisitions that calculates loan pools and portfolios worthiness; and Mozart for Originations, an automated underwriting system. Overture Technologies was founded in 2000 and is based in Bethesda, Maryland.

Aquestive Therapeutics

Debt Financing in 2008
Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Orchestro

Series C in 2008
Orchestro develops a software-as-a-service-based demand signal management platform. They enable consumer products companies to consolidate point-of-sale, internal, and syndicated data to create dashboards for category analysts, national account managers, and international representatives.

Innovative Biosensors

Venture Round in 2008
Innovative Biosensors' technology is built upon a foundation of a genetically engineered biosensor that allows for extremely rapid testing of analytes, providing high levels of sensitivity and specificity. The patented, self-contained biosensor system is capable of generating a sensitive and specific result with minimal amount of reagents in minutes, making it a cost-effective alternative to traditional laboratory testing. In addition, the biosensors can be engineered to detect one target or several targets of interest simultaneously and used to perform a wide variety of bioassays. Designed for real-time detection, minimally-skilled personnel can perform tests and analysis at the site of sampling using small, portable, space-saving instrumentation
Founded in late 2005, DigitalBridge Communications (DBC) provides broadband wireless to small and medium-sized communities of up to 150,000 people nationwide through the new WiMAX technology standard. In June 2007, DBC launched the first commercial WiMAX system in the United States in Rexburg, Idaho. Our strong, growing business benefits from the low-capital costs of WiMAX deployments and its high subscriber self-install rates. Building on the advantages of WiMAX economics, DBC has developed a highly scalable network deployment and variable-cost based back office platform that will enable us to bring broadband to communities nationwide. DBC is also committed to working with communities and schools to make high speed services available to local residents and students. We look forward to becoming an integral part of each community that we serve. We also expect to create partnerships with universities similar to our relationship with Ball State University in Muncie, Indiana. In January, 2007, Ball State University and DBC partnered to test licensed WiMAX self-install equipment. The test deployment was one of the first in the U.S. Since then, the collaboration continues to create the technical and business models needed to deliver WiMAX wireless broadband services profitably to traditionally underserved markets in Indiana and across the country.

Orchestro

Series C in 2007
Orchestro develops a software-as-a-service-based demand signal management platform. They enable consumer products companies to consolidate point-of-sale, internal, and syndicated data to create dashboards for category analysts, national account managers, and international representatives.

Verax Biomedical

Series E in 2007
Verax Biomedical was founded upon the singular vision of detecting bacterial contamination in cells and tissues intended for transfusion and transplantation. Recognizing that bacteria pose a unique infectious challenge in these life-giving tissues, they realized that novel approaches to detection were called for. While these cellular materials are routinely tested for viral contaminants, bacteria have posed a long-standing and heretofore poorly addressed challenge. Unlike viruses, bacteria can replicate outside of a living host, meaning they can grow in these cellular matrices during storage prior to transfusion or transplantation. This results in the unique dilemma of an infectious contaminant that can grow from unmeasurably low levels at the time of collection to massive levels at the time of transfusion or transplantation, posing a serious and often fatal risk to their recipient.

Aldagen

Series C in 2007
ALDAGEN is a biopharmaceutical company developing proprietary regenerative cell therapies that target significant unmet medical needs. We have four product candidates in clinical trials. Our most advanced product candidate is ALD-101. We are currently conducting a pivotal Phase 3 clinical trial of ALD-101 to evaluate its efficacy in improving umbilical cord blood, or cord blood, transplants used to treat inherited metabolic diseases in pediatric patients. We are also conducting or supporting Phase 1 or Phase 1/2 clinical trials of three other product candidates ALD--151 to improve cord blood transplants used for the treatment of leukemia; ALD-301 to treat critical limb ischemia; and ALD-201 to treat ischemic heart failure.

TerraGo Technologies

Series A in 2007
TerraGo Technologies delivers software applications that extend the access and application of maps and images for non-GIS users and customers. More than 850 organizations, including many defense and intelligence agencies, utility and energy companies, public safety departments, and environmental engineering teams depend on TerraGo software. The TerraGo Publisher Suite allows organizations to consume and optimize data from any source and create a geo-enabled PDF, also known as a GeoPDF. The TerraGo Collaboration Suite offers desktop, web-based, and mobile software applications that automate geospatial collaboration and information gathering.
Founded in late 2005, DigitalBridge Communications (DBC) provides broadband wireless to small and medium-sized communities of up to 150,000 people nationwide through the new WiMAX technology standard. In June 2007, DBC launched the first commercial WiMAX system in the United States in Rexburg, Idaho. Our strong, growing business benefits from the low-capital costs of WiMAX deployments and its high subscriber self-install rates. Building on the advantages of WiMAX economics, DBC has developed a highly scalable network deployment and variable-cost based back office platform that will enable us to bring broadband to communities nationwide. DBC is also committed to working with communities and schools to make high speed services available to local residents and students. We look forward to becoming an integral part of each community that we serve. We also expect to create partnerships with universities similar to our relationship with Ball State University in Muncie, Indiana. In January, 2007, Ball State University and DBC partnered to test licensed WiMAX self-install equipment. The test deployment was one of the first in the U.S. Since then, the collaboration continues to create the technical and business models needed to deliver WiMAX wireless broadband services profitably to traditionally underserved markets in Indiana and across the country.

Prestwick Pharmaceuticals

Series C in 2006
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.

Overture Technologies

Series B in 2006
Overture Technologies, Inc. develops and markets software solutions and consulting services to the residential lending and student financial aid industries. The company offers education finance solutions, including Conductor, an online financial aid solution, which provides personalized guidance, counseling, and services for students and their parents about their funding options; Student Loan Marketplace that enables users to compare loan terms from multiple lenders; and Amadeus, an underwriting and pricing solution for the student loan industry. It also provides Mortgage Finance Solutions, which promotes market efficiency and risk management for underwriting, pricing, servicing, and valuing mortgage loans and assets. The company's Mortgage Finance Solutions comprise Mozart for Special Servicing, which provides a set of alternatives for borrowers that can reduce repeat default rates and preserve the value of mortgage assets; Mozart for Acquisitions that calculates loan pools and portfolios worthiness; and Mozart for Originations, an automated underwriting system. Overture Technologies was founded in 2000 and is based in Bethesda, Maryland.

Vital Sensors

Venture Round in 2006
Vital Sensors, a medical device company, develops a remote cardiac sensor for congestive heart failure patients in the United States. Its remote cardiac sensors provide on-demand data monitoring for patients with cardiovascular diseases in hospitals and homes. The company was formerly known as Vital Sensors GmbH. Vital Sensors, Inc. was founded in 2002 and is headquartered in Richmond, Virginia.

Verax Biomedical

Series B in 2005
Verax Biomedical was founded upon the singular vision of detecting bacterial contamination in cells and tissues intended for transfusion and transplantation. Recognizing that bacteria pose a unique infectious challenge in these life-giving tissues, they realized that novel approaches to detection were called for. While these cellular materials are routinely tested for viral contaminants, bacteria have posed a long-standing and heretofore poorly addressed challenge. Unlike viruses, bacteria can replicate outside of a living host, meaning they can grow in these cellular matrices during storage prior to transfusion or transplantation. This results in the unique dilemma of an infectious contaminant that can grow from unmeasurably low levels at the time of collection to massive levels at the time of transfusion or transplantation, posing a serious and often fatal risk to their recipient.

Prestwick Pharmaceuticals

Series B in 2004
Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company offers products for restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals was founded in 2002 and is based in Washington, District of Columbia.

PaylinX

Series B in 2000
PaylinX is focused on the design, development, and marketing of POS software solutions. It offers support services for its products. PaylinX offers a payment server that is able to manage the authorization and settlement of credit card and other payment transactions in real-time. It also offers a payment solution that enables businesses to accept and process payment transactions through multiple enterprise sales channels such as web storefronts, call centers, interactive voice response systems, in-store point-of-sale systems, and kiosks. PaylinX was acquired by Cybersource in July 2000. Paylinx was founded in 1994 and is based in Foster City, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.